GM23426
LCL from B-Lymphocyte
Description:
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A; LGMD2A
CALPAIN 3; CAPN3
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases Muscular Dystrophies CMD Specific |
Class |
Congenital Muscle Diseases |
Biopsy Source
|
Peripheral vein
|
Cell Type
|
B-Lymphocyte
|
Tissue Type
|
Blood
|
Transformant
|
Epstein-Barr Virus
|
Sample Source
|
LCL from B-Lymphocyte
|
Race
|
White
|
Ethnicity
|
Not Hispanic/Latino
|
Ethnicity
|
IRISH/POLISH/AMISH
|
Family History
|
N
|
Relation to Proband
|
proband
|
Confirmation
|
Clinical summary/Case history
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by LINE assay |
|
Gene |
CAPN3 |
Chromosomal Location |
15q15.1-q21.1 |
Allelic Variant 1 |
mRNA reading frame maintained; LIMB-GIRDLE MUSCULAR DYSTROPHY, TYPE 2A |
Identified Mutation |
598_612del |
|
Gene |
CAPN3 |
Chromosomal Location |
15q15.1-q21.1 |
Allelic Variant 2 |
I113T; LIMB-GIRDLE MUSCULAR DYSTROPHY, TYPE 2A |
Identified Mutation |
ILE113THR |
Remarks |
Clinically affected; onset of symptoms at age 20 years; donor subject is a compound heterozygote: one allele has a 15 bp deletion beginning at nucleotide 598 of the CAPN3 gene(598_612del) and the second allele has a T>C transition at nucleotide 338 (338T>C) resulting in the substitution of threonine for isoleucine at codon 113 [Ile113Thr (I113T)] |
Split Ratio |
1:5 |
Temperature |
37 C |
Percent CO2 |
5% |
Percent O2 |
AMBIENT |
Medium |
Roswell Park Memorial Institute Medium 1640 with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not Inactivated |
Substrate |
None specified |
Subcultivation Method |
dilution - add fresh medium |
Supplement |
- |
|
|